Test Stock 25 (TE25)

ONLY a breakdown in the DEAL seems a likely candidate for a CRASH. but it has to be decisive. TACO is not likely to bite unless his humiliation gest the better of him. I EXPECTED him to be FORCED to fight instead of signing such an embarrassing defeat deal. I was WRONG. But IRAN is pushing it for

#DDAmanda Chart on $TSLA.

Check our 4th of July Special! https://DDAmanda.com

https://DDAmanda.com/Charts/DDAmandaTSLA.jpg

#DDAmanda

Z

FDA sanity returning.

Thanks Kiwi👍

GL...

Interesting read -
Wall Street Peer ComparisonsTo gauge where a successful medical device company in this niche can trade, retail investors often look at peer companies targeting localized cancer therapies:Company / Asset ClassClinical StageTypical

Market Cap Visualized Equiv

Thanks for sharing the details on the Duke/Schaal ELP + I-131 work.

The 2022 Nature Biomedical Engineering paper showed impressive preclinical results in mouse pancreatic cancer models (strong tumor regression, especially combined with nanoparticle paclitaxel). That’s meaningful data

97,11,5,71

I suggest people read your informative IFUS post again so that it makes sense with my comments

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177740678

YOU stated

If I were the interim CEO of IFUS right now, what would I do? Let's just set

UNCY's UniSource hub .
I suggest you all read up on this B2B plan UNCY is starting to make it really easy for dialysis centers to prescribe , store and bill for OLC .
Its designed to over come a lot of the hurdles , drug co's face launching new drugs into a field dominated by Freseniu

Exactly eagle8.
I think once we use DCVax-L plus Poly-ICLC, DCVax-D+ and aDC1 treatments in other cancer types we will see tremendous price movement.

Well, I don’t have my shares yet so they are worth nothing. More optimistic now that I might actually get them. 

Let the piggy bank eat .


The excitement builds

You  as well aqua

Hell yeah kj thanks for all your DD much appreciated let's go FITY

In over 25 years

It's quite a feature, isn't it?

What seems to always be missing here is that RadioGel was NOT the first thermogel with a radionuclide. It's even in their "prior art" section on their original patent from 1998!

And there have been many oth

starric, as usual, thanks for your posts.

The ultimate goal for NWBO is, of course, DCvax-Direct.
With the Kalinski method, aDCs, we won't need many adjuvants anymore.
Then only the companies with the most necessary adjuvants will benefit.
And there aren't that ma

Brazen. Boilerplate noise no, but boilerplate regardless. It's regulatory language the company has to keep repeating until the regulator approves the product. When I noted the language was also written to protect the company from litigation, I was referring to the whole regulatory document. Its car

$250K IS THE MAGIC NUMBER!  
$250,000 profit will get the PPS to COPPER @ P/E = 1,000 (not unusual for stocks turning profitable for the first time and with increasing future growth/revenue/profit projections).  This will happen when investors are confident the profit will be achieved, likely

16 years of the same Ruse. No one is Fooled

Also carefully read section 2.6.9. Discussion on clinical safety.

That safety discussion is not comparable to a normal approved-drug safety review where risks are identified, quantified, labelled and managed. CHMP found that blarcamesine’s safety package was too small for a large chr

Check video out at 3:55 and 5:11.

New CEO took over 1.5 years ago. Lots of trial data in the last year shows the efficacy of Revyve. Recent video says this is a good time for entry to the US market, due to changes in Medicare rules last year pushing skin subs (competitors to KNBIF) out of business. https://wallstreetanalyzer.com/202